BackParabilis Medicines Overview

Parabilis Medicines Total Liabilities

Parabilis Medicines's total liabilities is $130M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$127.53M

Peer trimmed avg / median

Loading

Parabilis Medicines Total Liabilities History

Loading

Parabilis Medicines vs. peers: Total Liabilities Comparison

Loading

Parabilis Medicines Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Parabilis Medicines (PBLS) FAQ

Parabilis Medicines (PBLS) currently reports a total liabilities of $130M as of June 2026. Use the charts on this page to explore Parabilis Medicines's total liabilities history and peer comparisons.

Parabilis Medicines reported $130M in total liabilities as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Parabilis Medicines, and consider following PBLS for alerts when major investors trade the stock.

Parabilis Medicines is classified in the Healthcare sector. On total liabilities, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PBLS with unrelated industries.